1. Home
  2. BTQ vs SPRY Comparison

BTQ vs SPRY Comparison

Compare BTQ & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BTQ Technologies Corp.

BTQ

BTQ Technologies Corp.

HOLD

Current Price

$3.68

Market Cap

831.4M

Sector

N/A

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$7.89

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTQ
SPRY
Founded
1983
2015
Country
Canada
United States
Employees
35
159
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
831.4M
788.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BTQ
SPRY
Price
$3.68
$7.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.00
$40.00
AVG Volume (30 Days)
5.3M
1.9M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
$2,332.99
$87.40
Revenue Next Year
N/A
$81.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$6.66
52 Week High
$16.00
$18.63

Technical Indicators

Market Signals
Indicator
BTQ
SPRY
Relative Strength Index (RSI) 39.43 41.19
Support Level $2.33 $7.41
Resistance Level $7.21 $8.61
Average True Range (ATR) 0.59 0.57
MACD -0.25 -0.16
Stochastic Oscillator 1.18 12.87

Price Performance

Historical Comparison
BTQ
SPRY

About BTQ BTQ Technologies Corp.

BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: